TY  - GEN
AU  - Galili,Naomi
AU  - Raza,Azra
TI  - Immunomodulatory drugs in myelodysplastic syndromes
SN  - 1744-7658
PY  - 2006///0818
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Angiogenesis Inhibitors
KW  - adverse effects
KW  - Animals
KW  - Apoptosis
KW  - drug effects
KW  - Blood Transfusion
KW  - Cell Lineage
KW  - Cells, Cultured
KW  - Chromosome Deletion
KW  - Chromosomes, Human, Pair 5
KW  - ultrastructure
KW  - Clinical Trials as Topic
KW  - Cytokines
KW  - physiology
KW  - Drug Evaluation, Preclinical
KW  - Drugs, Investigational
KW  - therapeutic use
KW  - Erythrocyte Transfusion
KW  - Erythropoiesis
KW  - Female
KW  - Hematopoietic Stem Cells
KW  - Humans
KW  - Immunologic Factors
KW  - Lenalidomide
KW  - Male
KW  - Middle Aged
KW  - Myelodysplastic Syndromes
KW  - drug therapy
KW  - NF-kappa B
KW  - antagonists & inhibitors
KW  - Neutropenia
KW  - chemically induced
KW  - Pilot Projects
KW  - Thalidomide
KW  - Thrombocytopenia
KW  - Tumor Necrosis Factor-alpha
N1  - Publication Type: Journal Article; Review
UR  - https://doi.org/10.1517/13543784.15.7.805
ER  -